These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 34858208)

  • 1. Biocompatible Nanomaterials as an Emerging Technology in Reproductive Health; a Focus on the Male.
    Fraser B; Peters AE; Sutherland JM; Liang M; Rebourcet D; Nixon B; Aitken RJ
    Front Physiol; 2021; 12():753686. PubMed ID: 34858208
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extracellular vesicle-mediated delivery of molecular compounds into gametes and embryos: learning from nature.
    Barkalina N; Jones C; Wood MJ; Coward K
    Hum Reprod Update; 2015; 21(5):627-39. PubMed ID: 26071427
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Silicon nanomaterials platform for bioimaging, biosensing, and cancer therapy.
    Peng F; Su Y; Zhong Y; Fan C; Lee ST; He Y
    Acc Chem Res; 2014 Feb; 47(2):612-23. PubMed ID: 24397270
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanosize drug delivery system.
    Mukherjee B
    Curr Pharm Biotechnol; 2013; 14(15):1221. PubMed ID: 25106648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design principles of bioinspired interfaces for biomedical applications in therapeutics and imaging.
    Shih CP; Tang X; Kuo CW; Chueh DY; Chen P
    Front Chem; 2022; 10():990171. PubMed ID: 36405322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chitosan-based nanomaterials: a state-of-the-art review.
    Shukla SK; Mishra AK; Arotiba OA; Mamba BB
    Int J Biol Macromol; 2013 Aug; 59():46-58. PubMed ID: 23608103
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent advances on biocompatible and biodegradable nanoparticles as gene carriers.
    Mokhtarzadeh A; Alibakhshi A; Yaghoobi H; Hashemi M; Hejazi M; Ramezani M
    Expert Opin Biol Ther; 2016 Jun; 16(6):771-85. PubMed ID: 26998622
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bioactivity of Hybrid Polymeric Magnetic Nanoparticles and Their Applications in Drug Delivery.
    Mohammed L; Ragab D; Gomaa H
    Curr Pharm Des; 2016; 22(22):3332-52. PubMed ID: 26853596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biodegradable Inorganic Nanoparticles for Cancer Theranostics: Insights into the Degradation Behavior.
    Zhou H; Ge J; Miao Q; Zhu R; Wen L; Zeng J; Gao M
    Bioconjug Chem; 2020 Feb; 31(2):315-331. PubMed ID: 31765561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toxicity of Nanoparticles on the Reproductive System in Animal Models: A Review.
    Brohi RD; Wang L; Talpur HS; Wu D; Khan FA; Bhattarai D; Rehman ZU; Farmanullah F; Huo LJ
    Front Pharmacol; 2017; 8():606. PubMed ID: 28928662
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nanoparticle depots for controlled and sustained gene delivery.
    Li Z; Ho W; Bai X; Li F; Chen YJ; Zhang XQ; Xu X
    J Control Release; 2020 Jun; 322():622-631. PubMed ID: 32194173
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention of microbial biofilms - the contribution of micro and nanostructured materials.
    Grumezescu AM; Chifiriuc CM
    Curr Med Chem; 2014; 21(29):3311. PubMed ID: 24606506
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and toxicity of nanomaterials for ocular drug delivery applications.
    Mehra NK; Cai D; Kuo L; Hein T; Palakurthi S
    Nanotoxicology; 2016 Sep; 10(7):836-60. PubMed ID: 27027670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of surface functionality in determining nanoparticle cytotoxicity.
    Kim ST; Saha K; Kim C; Rotello VM
    Acc Chem Res; 2013 Mar; 46(3):681-91. PubMed ID: 23294365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Theranostic nanoparticles engineered for clinic and pharmaceutics.
    Ma X; Zhao Y; Liang XJ
    Acc Chem Res; 2011 Oct; 44(10):1114-22. PubMed ID: 21732606
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overcoming the Challenges of siRNA Delivery: Nanoparticle Strategies.
    Shajari N; Mansoori B; Davudian S; Mohammadi A; Baradaran B
    Curr Drug Deliv; 2017; 14(1):36-46. PubMed ID: 27538460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Controlling the actuation of therapeutic nanomaterials: enabling nanoparticle-mediated drug delivery.
    Delehanty JB; Breger JC; Gemmill KB; Stewart MH; Medintz IL
    Ther Deliv; 2013 Nov; 4(11):1411-29. PubMed ID: 24228991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emerging Biomedical Applications of Enzyme-Like Catalytic Nanomaterials.
    Cormode DP; Gao L; Koo H
    Trends Biotechnol; 2018 Jan; 36(1):15-29. PubMed ID: 29102240
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional DNA-containing nanomaterials: cellular applications in biosensing, imaging, and targeted therapy.
    Liang H; Zhang XB; Lv Y; Gong L; Wang R; Zhu X; Yang R; Tan W
    Acc Chem Res; 2014 Jun; 47(6):1891-901. PubMed ID: 24780000
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential toxicity of engineered nanoparticles in mammalian germ cells and developing embryos: treatment strategies and anticipated applications of nanoparticles in gene delivery.
    Das J; Choi YJ; Song H; Kim JH
    Hum Reprod Update; 2016 Sep; 22(5):588-619. PubMed ID: 27385359
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.